Industry News & Literature
Stay ahead with expert-curated flow cytometry & cell/gene therapy news, landmark publications (including OMICs),
and fresh open-access research — all centralized to save you hours every week.
Featured Industry News
Handpicked headlines in flow cytometry & cell/gene therapy. Non-members see a preview; members get the full feed.
September 14, 2026 – Flow Cytometry
Waters Launches FACSDiscover A7 With Standardization at the Center of Spectral Cytometry
• Supports routine 50+ parameter experiments with up to five lasers and 78 fluorescence detectors
• FACSTruQ combines calibration, automated setup, and quality control
• Waters reports <10% CV across more than 50 dyes in internal testing
• Standardization is becoming a central competitive feature in spectral cytometry
September 9, 2026 – Flow Cytometry
Sysmex and Cytek Join Forces to Expand Clinical Spectral Cytometry Across Europe
• The collaboration covers more than a dozen European countries
• Sysmex automation and routine clinical workflows are being paired with Cytek spectral technology
• Leukemia, lymphoma, and MRD are important potential applications
• Clinical spectral cytometry is increasingly being built as an integrated workflow
October 1, 2026 – Flow Cytometry
Agilent Launches NovoStation to Automate Flow Cytometry Sample Preparation
• NovoStation automates reagent cocktailing and sample washing
• Agilent reported >90% reduction in hands-on time in validation studies
• The platform integrates with compatible NovoCyte instruments and NovoExpress software
• Pre-analytical automation is becoming an important route to cytometry standardization
September 17, 2026 – CGT
FDA Approves FAYUVI, the First Treatment for Sanfilippo Syndrome Type A
• FAYUVI is the first FDA-approved treatment for Sanfilippo syndrome type A
• The indication is for pediatric patients with preserved neurodevelopmental function
• The therapy uses AAV-mediated delivery of a functional SGSH gene
• The approval is an important milestone for pediatric CNS gene therapy
September 8, 2026 – CGT
Bristol Myers Reports Positive Pivotal Results for GPRC5D-Directed CAR-T Arlo-cel
• QUINTESSENTIAL met its primary overall-response endpoint
• Arlo-cel targets GPRC5D rather than BCMA
• The trial enrolled heavily pretreated patients previously exposed to BCMA-directed therapy
• A successful GPRC5D CAR-T could create a new treatment pathway after BCMA failure
September 14, 2026 – CGT
Cellectis Pivots From Ex Vivo Cell Therapy Toward In Vivo Gene Editing
• Cellectis is repositioning itself around in vivo gene editing
• Lead programs .HEAL-101 and .HEAL-201 target severe dyslipidemias
• Internal development of lasme-cel and eti-cel will end
• The pivot reflects a broader industry movement toward direct in vivo genetic engineering
Curated Literature Highlights
2020-07-15 – Cytometry Part A
OMIP-069: 40-Color Full-Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets of the Human Peripheral Blood
What it is: A community-adopted, 40-color spectral panel and workflow that unlocked routine, high-parameter immunophenotyping on full-spectrum instruments.
Why landmark (metrics): Cited well over 100 times (PubMed shows “Cited by” >300); method has become a go-to reference for building large spectral panels across core facilities.
2021-12-02 – Blood
2021 Update on MRD in Acute Myeloid Leukemia: A Consensus Document From the European LeukemiaNet MRD Working Party
What it is: The global standard-setting MRD guideline integrating flow cytometry (and molecular) with thresholds, time points, and reporting rules used in trials and clinical care.
Why landmark (metrics): Cited >600 times and directly drives assay design/interpretation and clinical decisions worldwide; widely implemented by hospital and reference labs.
2021-09-20 – Cytometry Part A
Full Spectrum Flow Cytometry as a Powerful Technology for Cancer Immunotherapy Research
What it is: A practice-oriented review that codified best practices for spectral instrumentation, panel design, unmixing, and analysis in immuno-oncology.
Why landmark (metrics): Cited ~110 times; catalyzed rapid adoption of spectral cytometry across IO programs and cores by providing a clear, implementable playbook.
How SuperNova Flow Cytometry Saves You Time
No more endless PubMed searches or scattered Google alerts —
our curated hub saves hours every week, so you can focus on discovery and innovation.
Save Hours
Members cut down research time by accessing centralized news and peer-reviewed literature.
Stay Focused
Skip irrelevant updates — our expert curation highlights only what impacts your work.
.
Trusted Sources
Every article comes from leading journals, conferences, and open-access databases.
.
Your Competitive Edge in Flow Cytometry & CGT
Join SuperNova Flow Cytometry to access curated industry news, landmark publications, and member-only resources —
all designed to save you time and keep you ahead of the curve.
ASCP- and ASC-accredited CMLE credits included with every accredited-course.